Original article by Paul Karp
The Guardian Australia – Page: Online : 13-May-21
Australia is continuing to resist a global push to waive intellectual property protections for COVID-19 vaccines. Pfizer has used its submission to a parliamentary inquiry into vaccine fraud to argue that rather than increasing global supply of vaccines, a waiver may in fact make it more difficult to manufacture vaccines due to increased competition for raw materials. Pfizer has also highlighted the increased risk of Australians being offered counterfeit vaccines by scammers. Meanwhile, Moderna has advised that the federal government has agreed to buy 25 million doses of its mRNA-based vaccine, including 10 million doses in 2021. It is also holding talks about manufacturing the two-dose vaccine in Australia.
PFIZER AUSTRALIA PTY LTD, PFIZER INCORPORATED, MODERNA INCORPORATED
Original article by Paul Sakkal, Melissa Cunningham, Liam Mannix, Rachel Clun, Emma Koehn
The Age – Page: Online : 22-Apr-21
The Victorian government has announced that it will contribute $50m to the cost of establishing a facility to manufacture mRNA-based vaccines in Melbourne. Professor Colin Pouton of Monash University believes that this amount of funding would be sufficient to establish a facility for the local manufacturing of the COVID-19 vaccines that were developed by Pfizer and Moderna. He says Australia could begin producing these vaccines within a year, adding that this could be accelerated if CSL – which is producing AstraZeneca’s adenovirus-based vaccine – becomes involved. Australia currently receives limited supplies of the Pfizer vaccine.
MONASH UNIVERSITY, PFIZER INCORPORATED, MODERNA INCORPORATED, ASTRAZENECA PLC, CSL LIMITED – ASX CSL
Original article by Roy Morgan
Market Research Update – Page: Online : 12-Apr-21
Now 83% of Australians have either already been vaccinated (7%), are willing to be vaccinated (69%) or would be willing to be vaccinated once the Pfizer vaccine becomes available (7%) – a total of 83% and an increase of 3% points since February, according to a special Roy Morgan Snap SMS survey conducted on Friday April 9 and Saturday April 10, 2021. Although the vast majority of Australians across all ages, genders, States and political party allegiances are willing to take the vaccine or have already done so, there is a political divide. Only 13% of L-NP voters say they will not be vaccinated, while more than 1-in-5 Labor and Green voters and those who vote for Independents and other parties express unwillingness to be vaccinated. The nation is evenly split on Prime Minister Scott Morrison’s handling of all COVID-19 related issues with 51% disapproving of Morrison’s handling of the pandemic and 49% approving. Clear majority support for Morrison’s handling of all COVID-19 related issues is recorded among Australians aged 65+, people in country areas, NSW, Queensland, WA and Tasmania, as well as L-NP supporters. In contrast a majority of younger Australians, women, people in capital cities and Victoria as well as supporters of the ALP and Greens disapprove.
ROY MORGAN LIMITED, LIBERAL PARTY OF AUSTRALIA, NATIONAL PARTY OF AUSTRALIA, AUSTRALIAN LABOR PARTY, AUSTRALIAN GREENS, AUSTRALIA. DEPT OF THE PRIME MINISTER AND CABINET
Original article by Remy Varga
The Australian – Page: 4 : 12-Apr-21
Prime Minister Scott Morrison has advised that the federal government will not set a revised target for all Australians who want to be vaccinated against COVID-19 to receive their first dose. Morrison said there are too many uncertainties regarding the vaccine rollout to set a new target, although he stated that the preference is still for all first doses to be administered by the end of 2021. The government has ordered an additional 20 million doses of Pfizer’s vaccine following a recommendation that people under the age of 50 should not be given the AstraZeneca vaccine due to concerns about blood clotting.
AUSTRALIA. DEPT OF THE PRIME MINISTER AND CABINET, ASTRAZENECA PLC, PFIZER INCORPORATED
Original article by Natasha Robinson
The Australian – Page: 1 & 4 : 9-Apr-21
The federal government has acted on the advice of the Australian Technical Advisory Group on Immunisation, which has recommended that AstraZeneca’s COVID-19 vaccine be restricted to people aged 50+. ATAGI stated that Pfizer’s vaccine is now preferred for people under the age of 50, after the European Medicines Agency concluded that there is a link between the AstraZeneca vaccine and a blood-clotting syndrome. Department of Health secretary Brendan Murphy says the government has acted out of an "abundance of caution", given that the extremely rare syndrome mainly affects younger people. Prime Minister Scott Morrison has conceded that the target date for giving all Australians at least one dose of a COVID-19 vaccine will need to be revised.
AUSTRALIAN TECHNICAL ADVISORY GROUP ON IMMUNISATION, AUSTRALIA. DEPT OF HEALTH, AUSTRALIA. DEPT OF THE PRIME MINISTER AND CABINET, ASTRAZENECA PLC, PFIZER INCORPORATED, EUROPEAN MEDICINES AGENCY
Original article by Paul Karp
The Guardian Australia – Page: Online : 7-Apr-21
About 855,000 doses of COVID-19 vaccines have been administered nationally since the federal government’s rollout began in late February. Prime Minister Scott Morrison says the rollout has fallen well behind schedule because the government has not received 3.1 million doses of the AstraZeneca vaccine from Europe. It had contracted to buy 3.5 million doses from Europe in total, and a government source doubts that the remaining 400,000 doses will be delivered. Meanwhile, some 2.5 million doses that have been produced by CSL in Melbourne have yet to be distributed; Morrison says they must first undergo batch testing to ensure that they are safe.
AUSTRALIA. DEPT OF THE PRIME MINISTER AND CABINET, ASTRAZENECA PLC, CSL LIMITED – ASX CSL
Original article by Natasha Robinson
The Australian – Page: 4 : 25-Jan-21
Australians are likely to be to access three probable COVID-19 vaccines over the coming 12 months, but the Moderna vaccine is currently not one of them. It and the Pfizer vaccine, which five millions Australia are due to receive, have shown the highest efficacy in clinical trials, but Australia has not been able to come to an agreement with Moderna over the supply of its vaccine. Epidemiologist Zoe Hyde says Australia should seriously consider using the Moderna vaccine in preference to the Oxford/Astra-Zeneca vaccine; Hyde says the Moderna vaccine will better prevent disease and is more likely to deliver herd immunity, which she contends should be Australia’s aim.
MODERNA INCORPORATED, PFIZER INCORPORATED, ASTRAZENECA PLC
Original article by Ronald Mizen
The Australian Financial Review – Page: 1 & 4 : 8-Jan-21
Prime Minister Scott Morrison announced on 7 January that Australians will start getting the COVID-19 vaccine from mid- to late February. Quarantine, border and frontline healthcare workers will be the first to get the vaccine, with Morrison saying around 80,000 people a week will initially receive it. The government has set a target of having four million people receive the vaccine by the end of March, with that figure to include around 500,000 aged and disability care residents and staff.
Original article by David Swan
The Australian – Page: 13 : 7-Jan-21
The Australian Information Industry Association has urged federal Health Minister Greg Hunt to appoint a representative from the technology industry to the working group tasked with the rollout of the COVID-19 vaccine. The AIIA believes a digital expert is needed on the group, as it is worried that the separate sourcing of ICT software and systems by state and territory governments risks a "disjointed approach" that could result in a less effective national vaccination program. Members of the AIIA include Telstra, Salesforce and Apple.
AUSTRALIAN INFORMATION INDUSTRY ASSOCIATION LIMITED, APPLE PTY LTD, TELSTRA CORPORATION LIMITED – ASX TLS
Original article by John Kehoe
The Australian Financial Review – Page: 5 : 6-Jan-21
Prime Minister Scott Morrison says he hopes lower numbers of COVID-19 cases in Sydney in recent days could see border restrictions between Victoria and New South Wales "eased as soon as possible". However, he has conceded he does not have the power to stop premiers and chief ministers closing their borders for health reasons. Morrison rejected criticisms that the federal government was taking too long to rollout a COVID-19 vaccine, saying that the Therapeutic Goods Administration needs to rigorously examine vaccine testing data, while vaccine batches in Australia will also need further testing.
AUSTRALIA. DEPT OF THE PRIME MINISTER AND CABINET